The content on this site is intended for healthcare professionals only
Prof Arnold Vulto speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about the critical quality attributes (CQA) of pharmacological agents.
He explains that these agents emit various functions - which can now be compared between the originator product and the biosimilar.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Key insights from lung cancer research at ASCO 2025
Cancer in emergencies: What can we do better to protect the most vulnerable?
Enhancing head and neck oncology: Key insights from the conference
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Lung Cancer
OncoAlert Round Up for September 15-21, 2023
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Neo-adjuvant therapy for different cancers in the Philippines
